| abstract |
An object of the present invention is to provide an agent for improving dullness of skin and lips. An agent for reducing desmoglein in stratum corneum cells, comprising astaxanthin as an active ingredient. When this agent is applied to skin with a disordered skin surface form, desmoglein in stratum corneum cells can be reduced, epidermal turnover can be improved, and stratum corneum cell area can be reduced. Therefore, this drug can be used to prevent, treat, or improve dullness of the skin or lips. [Selection] Figure 3 |